The U.S. International Trade Commission has decided not to review the initial decision made by the administrative law judge to terminate an investigation following a settlement between Medtronic and Axonics. The investigation, which began in April 2024, focused on alleged patent infringements related to medical programmers and printed circuit boards. After some claims were withdrawn and a settlement was reached, both parties filed a joint motion to end the investigation in February 2025. The Commission agreed with this resolution, noting that the decision complied with all necessary rules and did not oppose public interest.
Simple Explanation
The U.S. International Trade Commission decided not to keep looking into a disagreement between Medtronic and Axonics because they agreed to a truce, like when two kids stop arguing and shake hands. The grown-ups in charge said this was okay and didn't think it would cause any problems.